Buhat, Calixta T.

HRN: 29-48-58  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2026
CEFTRIAXONE 1G (VIAL)
08/16/2026
08/22/2026
IVTT
2g
OD
Cap-MR, Uti
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: